Viking Therapeutics Inc (NASDAQ:VKTX) price on Thursday, May 01, fall -0.88% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $28.61.
A look at the stock’s price movement, the close in the last trading session was $28.87, moving within a range at $27.69 and $29.01. The beta value (5-Year monthly) was 0.831. Turning to its 52-week performance, $81.86 and $18.92 were the 52-week high and 52-week low respectively. Overall, VKTX moved 19.68% over the past month.
Viking Therapeutics Inc’s market cap currently stands at around $3.21 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-22.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VKTX is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 6 recommend VKTX as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
VKTX’s current price about 17.48% and 7.12% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.17, while 7-day volatility ratio is 7.32% and 9.65% in the 30-day chart. Further, Viking Therapeutics Inc (VKTX) has a beta value of 0.75, and an average true range (ATR) of 2.17. Analysts have given the company’s stock an average 52-week price target of $92.5, forecast between a low of $74 and high of $110. Looking at the price targets, the low is -158.65% off current price level while to achieve the yearly target high, price needs to move -284.48%. Nonetheless, investors will most likely welcome a -223.31% jump to $92.5 which is the analysts’ median price.
If we refocus on Viking Therapeutics Inc (NASDAQ:VKTX), historical trading data shows that trading volumes averaged 4.6 over the past 10 days and 4.85 million over the past 3 months. The company’s latest data on shares outstanding shows there are 112.29 million shares.
The 2.96% of Viking Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 73.26% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 25.46 million on 2025-04-15, giving us a short ratio of 6.02. The data shows that as of 2025-04-15 short interest in Viking Therapeutics Inc (VKTX) stood at 2721.0 of shares outstanding, with shares short rising to 24.21 million registered in 2025-03-14. Current price change has pushed the stock -28.89% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VKTX stock continues to rise going into the next quarter.
